Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

UCLA Team Develops Engineered Immune Cells to Combat Heart Disease

Sep 22, 2026 September 22, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A UCLA research team has developed engineered immune cells that target atherosclerotic plaques, which are responsible for many heart attacks and strokes. This advancement could have implications for healthcare in Iran, where cardiovascular diseases are prevalent. The findings were published in Circulation Research.

🔍 Quick Context Guide
💡 Bottom Line: The development of engineered immune cells at UCLA could pave the way for new heart disease treatments, particularly relevant for countries like Iran.

👥 Key Players

UCLA Research Team MENTIONED
Developers of engineered immune cells
"Their research could lead to new treatments for cardiovascular diseases, which are a major health issue in Iran."

📰 What Happened

A UCLA research team has engineered immune cells that specifically target and attack atherosclerotic plaques, which contribute to heart attacks and strokes. This breakthrough was published in the journal Circulation Research.

  • The engineered immune cells recognize three harmful cell types within plaques.
  • Cardiovascular diseases are a leading cause of mortality in Iran.

💡 Why It Matters

🇮🇷 For Iran: Cardiovascular diseases are prevalent in Iran, and new treatments could significantly improve public health outcomes.
🌍 Regional: Improved healthcare technologies could enhance regional medical capabilities and collaboration.
🌐 International: This research may attract international interest and funding for further studies in cardiovascular health.

📚 Background

Atherosclerosis is a condition characterized by the buildup of fatty deposits in arteries, leading to serious cardiovascular issues. Heart disease is a leading cause of death worldwide, including in Iran.

Cardiovascular diseases Atherosclerosis
📡 Source: NEUTRAL
📊 Confidence: 70%
The findings are published in a reputable scientific journal, indicating a level of credibility in the research.

A UCLA research team has engineered a new type of immune cell that attacks atherosclerotic plaques—the fatty buildup inside artery walls that drives most heart attacks and strokes. These engineered cells work by recognizing three harmful cell types within plaques. The paper is published in the journal Circulation Research.

🏷️ Entities Mentioned

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →